S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NASDAQ:BIOT

Biotech Acquisition - BIOT Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$10.14
▼
$10.19
50-Day Range
$10.08
▼
$10.32
52-Week Range
$8.30
▼
$10.41
Volume
44,400 shs
Average Volume
244,605 shs
Market Capitalization
$291.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIOT stock logo

About Biotech Acquisition (NASDAQ:BIOT) Stock

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Receive BIOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOT Stock News Headlines

March 28, 2023 | marketwatch.com
Global Pharmaceutical Grade HPMC Market 2023 Global Production, Value, Supply or Demand 2031 Forecasts
March 28, 2023 | marketwatch.com
Pharmaceutical Logistics Market: Challenges and Standardization 2023-2031
March 28, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
March 28, 2023 | marketwatch.com
New Report Examines the Nano Pharmaceutical Market Forecast to 2031
March 27, 2023 | marketwatch.com
Pharmaceutical Grade Phycocyanin Market 2023-2030 Supply Demand Report, Industry Analysis, and Top Companies
March 27, 2023 | marketwatch.com
Pharmaceutical Inspection Equipment Market: Key Players and Strategies for Future Growth by 2023-2027
March 26, 2023 | marketwatch.com
Detailed Analysis of Specialty Pharmaceutical Market Forecast 2023 to 2028
March 24, 2023 | finance.yahoo.com
Magnetic North Acquisition Corp. Announces New Chief Financial Officer
March 28, 2023 | Legacy Research (Affiliate) (Ad)
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
March 24, 2023 | marketwatch.com
Biotech Seeds Market [2023-2030] | Industry Booms Globally | Comprehensive Research Report | Top Countries Insight
March 24, 2023 | msn.com
SPAC Graf IV signs merger LOI with immunotherapy developer NKGen Biotech
March 24, 2023 | marketwatch.com
Biotech Flavors Market 2023 Size and Forecast to 2030
March 23, 2023 | finance.yahoo.com
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination
March 23, 2023 | marketwatch.com
Graf Acquisition Corp. IV, NKGen Biotech, Inc. Plan Combination
March 23, 2023 | marketwatch.com
Biotech-based Aroma Ingredients Market: Forecast for 2023-2027 with Emerging Technologies
March 23, 2023 | marketwatch.com
Pharmaceutical Lipids Market: Trends and Innovations Shaping the Future Industry 2023-2027
March 22, 2023 | finance.yahoo.com
BGL Announces the Sale of lino Biotech to Miltenyi Biotec
March 22, 2023 | msn.com
SPAC Maxpro shareholders approve merger with biotech firm Apollomics
March 22, 2023 | marketwatch.com
2023 Biotechnology Market: Recent Business Advancements and Future Opportunities till 2030
March 22, 2023 | benzinga.com
Ally Biotech Acquires THC 'Chill Pill' Soft Gel Cap Line From Desert Medical Campus
March 21, 2023 | marketwatch.com
Biotech-based Aroma Ingredients Market Is Expected To Gain Market Growth In The Forecast Period Of 2023 To 2030
March 21, 2023 | finance.yahoo.com
Ally Biotech Announces Acquisition of Popular THC "Chill Pill" Soft Gel Cap Line From Desert Medical Campus, Inc.
March 21, 2023 | msn.com
SPACs are back as British biotech firm Zura launches UK’s first Nasdaq listing in 2023
March 20, 2023 | marketwatch.com
Global Specialty Pharmaceutical Market Size by Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Other) Forecast from 2023 to 2028
March 20, 2023 | marketwatch.com
Pharmaceutical Grade HPMC Market : Down-Stream And Upstream Value Chain Analysis With Top Countries Data
March 20, 2023 | marketwatch.com
Global Pharmaceutical Grade PVDC Market Size by Type (PVDC Resins, PVDC Latex) Forecast from 2023 to 2028
March 20, 2023 | marketwatch.com
Global Fermentors Market Size by Application (Industrial, Biotechnology, Agriculture, Other) Forecast from 2023 to 2028
See More Headlines
Receive BIOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOT Company Calendar

Today
3/28/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BIOT
CUSIP
N/A
CIK
1825413
Web
bioacq.com
Phone
212-227-1905
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,860,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-42.22%
Return on Assets
3.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.95) per share
Price / Book
-10.68

Miscellaneous

Outstanding Shares
28,750,000
Free Float
23,288,000
Market Cap
$291.81 million
Optionable
Not Optionable
Beta
-0.12

Key Executives

  • Dr. Michael Shleifer Ph.D. (Age 48)
    Chairman & CEO
  • Mr. Thomas Fratacci (Age 44)
    CFO & Treasurer
  • Mr. Ivan Jarry (Age 44)
    Chief Operating Officer
  • Mr. Albert F. Hummel M.B.A. (Age 76)
    Chief Investment Officer & Director

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













BIOT Stock - Frequently Asked Questions

What is Biotech Acquisition's stock symbol?

Biotech Acquisition trades on the NASDAQ under the ticker symbol "BIOT."

Who are Biotech Acquisition's major shareholders?

Biotech Acquisition's stock is owned by many different retail and institutional investors. Top institutional investors include Glazer Capital LLC (7.94%), Aristeia Capital LLC (5.30%), Berkley W R Corp (1.69%), RPO LLC (1.25%), Bank of Montreal Can (0.98%) and Mizuho Securities USA LLC (0.87%).

What is Biotech Acquisition's stock price today?

One share of BIOT stock can currently be purchased for approximately $10.15.

How much money does Biotech Acquisition make?

Biotech Acquisition (NASDAQ:BIOT) has a market capitalization of $291.81 million.

How can I contact Biotech Acquisition?

Biotech Acquisition's mailing address is 545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY, 10001. The official website for the company is bioacq.com. The company can be reached via phone at 212-227-1905.

This page (NASDAQ:BIOT) was last updated on 3/28/2023 by MarketBeat.com Staff